GET THE APP
Oncolytic Virus Innovations | Open Access Journals
Journal of Oncology Medicine & Practice

Journal of Oncology Medicine & Practice

ISSN: 2576-3857

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Oncolytic Virus Innovations

An oncolytic virus is a virus that contaminates and executes growth cells in a particular way. As lysis devastates the tainted disease cells, they discharge new irresistible virus particles to aid in obliterating the remaining tumors. Oncolytic viruses are thought not only to cause the tumor cells to instantly decimate, but also to protect the host against invulnerable tumor responses. The potential of viruses as an anti-cancer agent was first realized in the early 20th century, although coordinated research efforts did not commence until the 1960s. A variety of viruses have been clinically tested as oncolytic agents, including reovirus, Newcastle disease virus, adenovirus, herpes simplex, measles, and vaccinia. Most existing oncolytic viruses are designed for tumor selectivity, while naturally occurring examples such as senecavirus and reovirus contribute to clinical trials.

                                                   

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 142

Journal of Oncology Medicine & Practice received 142 citations as per Google Scholar report

Citation image
Journal of Oncology Medicine & Practice peer review process verified at publons
Publon image

Indexed In

Related Links

 

Open Access Journals

arrow_upward arrow_upward